Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area epigenetics parp'

Search results for: 'research area epigenetics parp'

Items 1-10 of 59

Page
per page
  1. Veliparib dihydrochloride
    A3958 Veliparib dihydrochloride
    Target: PARP
    Summary: PARP-1/PARP-2 inhibitor
      ≥31.7 mg/mL
  2. PJ34
    A3729 PJ34
    Target: PARP
    Summary: PARP-l inhibitor
      ≥50.9 mg/mL
  3. A-966492
    A4160 A-966492
    Target: PARP
    Summary: PARP-1/-2 inhibitor, highly potent
      ≥32.4 mg/mL
  4. UPF 1069
    A4163 UPF 1069
    Target: PARP
    Summary: Selective PARP2 inhibitor
      insoluble in H2O; ≥12.7 mg/mL
  5. Vorinostat (SAHA, MK0683)
    A4084 Vorinostat (SAHA, MK0683)
     9 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor
      insoluble in EtOH; insoluble in H2O; ≥4.41 mg/mL
  6. Mocetinostat (MGCD0103, MG0103)
    A4089 Mocetinostat (MGCD0103, MG0103)
     2 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor,isotype-selective and potent
      insoluble in EtOH; insoluble in H2O; ≥19.8 mg/mL
  7. AZD1208
    A3962 AZD1208
    Target: Pim
    Summary: PIM kinase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥18.95 mg/mL
  8. Tubacin
    A4501 Tubacin
     3 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC6 inhibitor,potent,selective,reversible,cell-permeable
      insoluble in EtOH; insoluble in H2O; ≥7.19 mg/mL
  9. Ruxolitinib (INCB018424)
    A3012 Ruxolitinib (INCB018424)
     4 Citation
    Target: JAK
    Summary: JAK inhibitor
      insoluble in H2O; ≥15.32 mg/mL
  10. Tofacitinib (CP-690550) Citrate
    A4135 Tofacitinib (CP-690550) Citrate
     2 Citation
    Target: JAK
    Summary: Potent JAK inhibitor
      ≥25.22 mg/mL

Items 1-10 of 59

Page
per page
Shop By
Now Shopping by
  1. Category Signaling Pathways Remove This Item
  2. Reported Experiments Cell Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Apoptosis 2item
  2. Chromatin/Epigenetics 53item
  3. DNA Damage/DNA Repair 20item
  4. Microbiology & Virology 1 item
  5. Cell Cycle/Checkpoint 13item
  6. Ubiquitination/ Proteasome 1 item
  7. JAK/STAT Signaling 9item
  8. Angiogenesis 1 item
  9. Stem Cell 2item
  10. Membrane Transporter/Ion Channel 1 item
  11. Neuroscience 2item
Specificity
  1. Selective 35item
Reversibility
  1. Reversible 2item
  2. Irreversible 1 item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Histone Deacetylases (HDACs) 12item
  3. Aurora Kinases 13item
  4. EZH2 1 item
  5. Bromodomains 2item
  6. FLT3 5item
  7. PLK 1 item
  8. VEGFR 2item
  9. RET 1 item
  10. Bromodomain-containing proteins(BRDs) 1 item
  11. Hydrolase 1 item
  12. MEK 1 item
  13. FGFR 1 item
  14. Pim 1 item
  15. Sir2-like Family Deacetylases (Sirtuins) 2item
  16. PP1 1 item
  17. PP2A 1 item
  18. Src 3item
  19. Trk Receptors 1 item
  20. STAT 1 item
  21. JAK 9item
  22. Topoisomerases 1 item
  23. DNA Methyltransferases 1 item
  24. LRRK2 1 item
  25. PARP 6item
  26. ALK 1 item
  27. Histamine H1 Receptors 1 item
  28. Hck 1 item
  29. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  30. Cytidine deaminases 1 item
  31. PP4 1 item
  32. c-RET 1 item
  33. VEGFR3/FLT4 1 item
  34. NTRK1/TRKA 1 item
  35. CSF-1R/c-Fms 1 item
  36. PTP 1 item
  37. p53 1 item
  38. Histone Acetyltransferases (HATs) 1 item
  39. Trx 1 item
  40. TYK2 1 item
  41. MUSK 1 item
  42. MAP3K 1 item
  43. Lck 1 item
  44. p21 1 item
  45. FGR 1 item
  46. YES 1 item
  47. Fyn 1 item
  48. ARG 1 item
  49. TRPC channel 1 item
  50. Sirtuin 1 item
Related Disease
  1. Acute Myeloid Leukemia 5item
  2. Bladder Cancer 2item
  3. Bladder Carcinoma 1 item
  4. Breast Cancer 6item
  5. Cancer 33item
  6. Cervical Cancer 1 item
  7. Chronic Lymphocytic Leukemia 1 item
  8. Colon Cancer 2item
  9. Colorectal Cancer 2item
  10. Glioblastoma 1 item
  11. Glioma 1 item
  12. HIV Infections 1 item
  13. Inflammatory Diseases 1 item
  14. Leukemia 1 item
  15. Lung Cancer 2item
  16. Melanoma 1 item
  17. Multiple Myeloma 1 item
  18. Myelofibrosis 1 item
  19. Neuroblastoma 1 item
  20. Neuronal Protection 1 item
  21. Ovarian Cancer 3item
  22. Pancreatic Cancer 2item
  23. Prostate Cancer 6item
  24. Psoriasis 1 item
  25. Renal Cancer 1 item
  26. Renal Cell Carcinoma 1 item
  27. Rheumatoid Arthritis 2item
  28. Thyroid Cancer 1 item
  29. Type 2 Diabetes 1 item